# | Filing Date | Period End Date | Type | Report Link |
---|---|---|---|---|
No Data found |
# | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
---|
New ETFs focusing on weight-loss drugs have launched. However, industry observers caution about their long-term prospects and t...
Companies from food and beverage to fitness are adapting to the increased demand for these drugs, hoping to capitalize on shift...
NICE recommends Eli Lilly's Mounjaro for obesity, omitting time limits applied to Novo Nordisk's Wegovy, opening new av...
- Reuters
Novo Nordisk has filed lawsuits against nine additional U.S. medical spas, wellness clinics, and pharmacies for selling impure ...